Navigation Links
Potential blood test for chronic sinusitis identified
Date:4/14/2008

s for inflammation, mucus thinners, saline irrigation, etc. Its difficult to show drugs are effective because its difficult to group patients together and measure their disease, says Dr. Kountakis.

He hopes further studies will enable both, revealing signature protein profiles for different types of chronic sinusitis as well as the degree of disease. The bottom line is we want to group patients according to their disease rather than just the general term chronic sinusitis, Dr. Kountakis says. If we can find a way to classify patients, group them together based on the specific disease they have, maybe we can get better outcomes and treat patients with better efficiency.

These objective measures should allow monitoring the effectiveness of current therapies and objectively reviewing new ones, he says.

In fact, even getting a handle on disease incidence is tough. The National Health Interview Survey, based on self-reports, says 14 to 16 percent of people in the United States have chronic sinusitis. A population-based study of the Olmsted County, Minnesota published in 2004 in Archives of Otolaryngology-Head & Neck Surgery put the incidence at 2 percent.

For this study, researchers analyzed protein expression in the blood using surface enhanced laser desorption ionization time-of-flight mass spectroscopy or SELDI-TOF-MS. The test is about 88 percent accurate.


'/>"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4412
Medical College of Georgia
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Medical errors cost US $8.8B, result in 238,337 potentially preventable deaths: HealthGrades study
2. Stem cell research leads to potential new therapy for rare blood disorder
3. New research shows benefits of ultrasound contrast agents outweigh potential risk to heart patients
4. Angina drug potentially useful against heart rhythm disorders
5. Neuronal regulators offer potential targets for cancer
6. Companies Not Fully Tapping Potential of Onsite Health Centers
7. Study Finds Potential Cause of Age-Related Macular Degeneration
8. More Clinical Data Required to Support European Approval of Desvenlafaxine as a Potential Treatment for Vasomotor Symptoms
9. New potential treatment for muscular dystrophy appears to be safe
10. Regenstrief Institute tapped by CDC to combat potentially catastrophic disease outbreaks
11. Research shows promise for potential new gene therapy strategy for muscle-wasting diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Potential blood test for chronic sinusitis identified
Potential blood test for chronic sinusitis identified
(Date:1/7/2009)...ings is Available at Albertsons stores throughout ... Jan. 7 Albertson,s LLC announced ...escription discount program today by introducing a...r 500 generic drugs. In addition, Albertsons has ...over 500 drugs that are already covered by this di...
(Date:1/7/2009)...ment Officials Will Explain Regulatory Plans for C...-19 in Washington , DC . , , WASHINGTON,...was incorporated into more than $60 billion in man...l grow to $2.6 trillion. By 2011, over $15 billion...ld--up from more than $3 billion in 2006. And indu...
(Date:1/7/2009)...ramic company strengthens global team , , DENVE...idiary of the largest manufacturer of technical ce...Steven Hughes has joined the company as Sales Mana...even will spearhead the business development and t... Europe and Latin America in addition to supportin...
(Date:1/7/2009)... Colo., Jan. 7 Zuma,s Rescue Ranch...ait, and three years of being self funded, Zuma,s ... and sponsorship! , , Zuma,s Rescue Ranch had ...on-profit charity we have been working with Behavi... Equine Assisted Psychotherapy for foster children...
Breaking Medicine News(10 mins):Health News:Albertson's LLC Launches $10.99 for 90-day Supply of Generic Drugs as Part of Rx-tra Savings Prescription Discount Program 2Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 2Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 3Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 4Health News:Dr. Steven Hughes Joins Medical Ceramics Provider: C5 Medical Werks 2
...nishing your unruly kids for rule-breaking, steali...u could just be penalising yourself!// Psycholog...ty of New South Wales evaluated a child-management...r-year- to eight-year-old boys who have "callous-u...
...heir wives at increased risk of long-term illness ...week's BMJ.// Exposure to environmental tobacco s... excess risk of coronary heart disease and lung ca... may also be linked to stroke and other cancers, t...
...ege on the victim's disposition and way of life, a...olness can act as an effective pain// reliever. Sc...ured out the chemicals that enable feelings of coo...onic pain. This could pave the way for improved ...
...out that Insulin resistance during adolescence is ...se in adulthood.// Obesity is indicated by a bod...rd off diabetes and heart disease is to ensure tha...od and adolescence, which will certainly reduce th...
Other Medicine News:Health News:Chinese Men Putting Wives at Risk of Early Death by Smoking 2
(Date:12/17/2008)...., Dec. 17 PEAK Surgical, Inc., a ...issue dissection system based on a,proprietary te...rug,Administration (FDA) has granted the company ...stem for cutting and coagulation of soft tissue du...nd throat), gynecologic,orthopedic, arthroscopic...
(Date:12/17/2008)...OLIS, France, December 17 /PRNewswire-FirstCall/ -...ounced positive results of a,pre-specified pooled...A) from,the 301, 302 and 303 pivotal phase 3 stud...owed a significant reduction in systolic and diast...roxen 500 mg bid over the whole 13 week,period (p...
(Date:12/16/2008)...s New Link Between Inflammation & Alzheimer,s ...wire/ -- The Roskamp Institute today announced tha...n inflammation and Alzheimer,s disease and have id...herapeutics for intervention in this disease. The... Ph.D., is detailed in the American Chemical Soci...
(Date:12/16/2008)...utics Technology Provided CML Biomarker Data for S...ire-FirstCall/ -- Synvista Therapeutics, Inc. ( ...lications demonstrating findings from studies that...tion end product (A.G.E.) called carboxymethyl-lys...line in renal function and arterial stiffness in o...
Breaking Medicine Technology:PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 2NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 3NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 4NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 5Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 2Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 3Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 2Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 3Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 4Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 5Monitoring exhaled nitric oxide does not help manage asthma 26570 1Monitoring exhaled nitric oxide does not help manage asthma 26570 2Monitoring exhaled nitric oxide does not help manage asthma 26570 3Marine debris will likely worsen in the 21st century 4970 1Marine debris will likely worsen in the 21st century 4970 2Marine debris will likely worsen in the 21st century 4970 3Marine debris will likely worsen in the 21st century 4970 4Aerolase Retains SMH Capital Inc to Advise on Corporate Expansion 7800 1Aerolase Retains SMH Capital Inc to Advise on Corporate Expansion 7800 2tootoo com 3A Chinas Farmers Welcome the New Trend of Organic Farming 7797 1tootoo com 3A Chinas Farmers Welcome the New Trend of Organic Farming 7797 2
...wswire-FirstCall/ --,Wyeth Pharmaceuticals, a divi... of pooled data from both hormone therapy arms of ...d today in the,Journal of the American Medical Ass...ncrease in coronary heart disease for women who,in...ublication also reports a statistically nonsignifi...
...mune, a,clinical stage nanomedicine company focuse...ifunctional, tumor-targeted therapies has,been sel...rican,Society of Clinical Oncology Annual Meeting ...will take place from 8:00 am to 12,noon on June 3....ent the poster abstract entitled "Preliminary Resu...
Other Medicine Technology:New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 2New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 3New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 4New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 5New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 6CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to,be Presented on June 3, 2007 2
Aluminum Stylette 16 with Adjustable Stop.
Ultra-Slip™ endotracheal tube guide for single-patient use only., ,Caution: Not MRI Compatible.
Slick® Disposable Endotracheal Stylet, Nylon-coated wire, Malleable core, Sureloc Stop helps maintain desired length for patient safety. Handle forming capability for better grip. Sterile. Single
...cal spine manipulation. Prevent dental and soft ti...e alternative to X-ray. Light-guided intubation is...he neck. This technique takes advantage of the ant...hagus. A well-defined, circumscribed glow can read...
Medicine Products: